Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations
Crossref DOI link: https://doi.org/10.1007/s40265-016-0628-6
Published Online: 2016-08-24
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barnfield, Paul C.
Ellis, Peter M.
License valid from 2016-08-24